Indian Trial of Tranexamic Acid in Spontaneous Intracerebral Haemorrhage
NCT05836831 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 3400
Last updated 2026-01-22
Summary
This multicenter, pragmatic randomized, open-label clinical trial aims to assess whether Tranexamic Acid improves outcomes in adult patients with spontaneous intracerebral haemorrhage.
The participants presenting within 4.5 hours of the onset of symptoms of stroke with intracerebral haemorrhage confirmed on Computed Tomography (CT Scan) will be randomized into two groups in a 1:1 ratio using a central online randomization. The treatment arm will consist of giving intravenously 2 grams of Tranexamic Acid in 100 ml 0.9% sodium chloride administered over 45 minutes. Control arm patients will receive standard of care treatment as per the institutional protocol. In both arms, intensive systolic blood pressure reduction to less than 140 mmHg will be done using antihypertensive medications, which has to be achieved within one hour and will be maintained over next seven days. The choice of antihypertensive drug will depend on the clinician's preference.
Both groups will have a repeat CT scan after 24 hours to check for any increase in the haematoma volume. Any deterioration in the neurological status will warrant urgent brain imaging. On day 7, the patient will be assessed for their NIHSS score and mRS score. On day 90, quality of life and the functional outcome will be assessed.
Conditions
- Intracerebral Hemorrhagic Stroke
Interventions
- DRUG
-
Tranexamic acid injection
The treatment arm will consist of giving intravenously 2 grams of Tranexamic Acid in 100 ml sodium chloride 0.9 % administered over 45 minutes.
Sponsors & Collaborators
-
Indian Council of Medical Research
collaborator OTHER_GOV -
Sree Chitra Tirunal Institute for Medical Sciences & Technology
collaborator OTHER_GOV -
Post Graduate Institute of Medical Education and Research, Chandigarh
collaborator OTHER -
St. Stephen's Hospital, Delhi
collaborator OTHER -
All India Institute of Medical Sciences
collaborator OTHER -
Amrita Institute of Medical Sciences & Research Center
collaborator OTHER -
Kasturba Medical College Manipal, India
collaborator UNKNOWN -
Institute of Neurosciences Kolkata
collaborator OTHER -
Bangur Institute of Neurosciences Kolkata, India
collaborator UNKNOWN -
Guwahati Neurological Research Center, Guwahati, India
collaborator UNKNOWN -
Baptist Christian Hospital, Tezpur, India
collaborator UNKNOWN -
National Institute of Mental Health and Neuro Sciences, India
collaborator OTHER -
Jawaharlal Institute of Postgraduate Medical Education & Research
collaborator OTHER_GOV -
Christian Medical College, Vellore, India
collaborator OTHER -
CARE Hospitals Hyderabad, India
collaborator UNKNOWN -
Lalitha Super Specialities Hospital Guntur, India
collaborator UNKNOWN -
Dr. Ramesh Cardiac and Multispeciality Hospital Guntur, India
collaborator UNKNOWN -
Government General Hospital Guntur, India
collaborator UNKNOWN -
Fortis Escorts Hospital Jaipur, India
collaborator UNKNOWN -
Institute of Medical Sciences of the Banaras Hindu University, India
collaborator OTHER -
Atal Institute of Medical Super Specilities, (AIMSS) Chamiana, Shimla
collaborator UNKNOWN -
All India Institute of Medical Sciences, Bhubaneswar
collaborator OTHER -
KLEs Dr. Prabhakar Kore Hospital & Medical Research Centre Balgaum, India
collaborator UNKNOWN -
Guru Gobind Singh Medical College & Hospital
collaborator OTHER -
PBM Hospital Bikaner, India
collaborator UNKNOWN -
Shree Krishna Hospital Pramukhswami Medical College Anand, India
collaborator UNKNOWN -
Apollo Excelcare Hospitals Guwahati, India
collaborator UNKNOWN -
Manipal Hospital Bangalore, India
collaborator UNKNOWN -
Artemis Hospital Gurgaon, India
collaborator UNKNOWN -
Dr. Kamakshi Memorial Hospital Chennai, India
collaborator UNKNOWN -
Bharati Vidyapeeth DTU Medical College Pune, India
collaborator UNKNOWN -
Aster MIMS Hospital Calicut, India
collaborator UNKNOWN -
Holy Spirit Hospital Mumbai, India
collaborator UNKNOWN -
Sparsh Superspeciality Hospital Bangalore, India
collaborator UNKNOWN -
King George's Medical University, Lucknow, India
collaborator UNKNOWN -
Assam Medical College, Dibrugarh, India
collaborator UNKNOWN -
KG Hospital and Post Graduate Medical Institute Coimbatore, India
collaborator UNKNOWN -
Tirunelveli Medical College, Tirunelveli, India
collaborator UNKNOWN -
Santokba Durlabhji Memorial Hospital, Jaipur, India
collaborator UNKNOWN -
Tezpur Medical College and Hospital, Assam, India
collaborator UNKNOWN -
Baby Memorial Hospital Calicut, India
collaborator UNKNOWN -
Institute of Human Behaviour and Allied Sciences Delhi, India
collaborator UNKNOWN -
The Calcutta Medical Research Institute, Kolkata, India
collaborator UNKNOWN -
Fortis Hospital Mulund Mumbai, India
collaborator UNKNOWN -
Government Medical College Trivandrum, India
collaborator UNKNOWN -
Ruby Hall Clinic, Pune, India
collaborator UNKNOWN -
Manipal Hospital Goa, India
collaborator UNKNOWN -
Christian Medical College and Hospital, Ludhiana, India
lead OTHER
Principal Investigators
-
Jeyaraj D Pandian, MD DM · Christian Medical College and Hospital, Ludhiana, Punjab, India
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-30
- Primary Completion
- 2026-11-30
- Completion
- 2026-11-30
Countries
- India
Study Locations
More Related Trials
-
INtravenous TNK for Acute isChemicsTroke in China
NCT04588337 ·Status: COMPLETED
-
Low-dose Aspirin Therapy in Patients With Ischemic Stroke and Microbleeds
NCT04504864 ·Status: UNKNOWN ·Phase: PHASE4
-
Intraarterial Stem Cells in Subacute Ischemic Stroke
NCT03080571 ·Status: COMPLETED ·Phase: PHASE1
-
Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds
NCT05032053 ·Status: RECRUITING
-
Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events(TRACE)
NCT04676659 ·Status: COMPLETED ·Phase: PHASE2
-
Intracerebral Transplantation of Autologous MSC Combined With Scaffold Product for Chronic Intracerebral Hemorrhage
NCT06361433 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
The Effect of Ginkgolide on Clinical Improvement of Patients With Acute Ischemic Stroke
NCT05663307 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Multicenter Analysis of Oral Anticoagulant-associated ICH - Part Two
NCT03093233 ·Status: COMPLETED
-
Pre-stroke Cognitive Status and Thrombolytic Therapy
NCT01713491 ·Status: COMPLETED
-
Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3)
NCT05965687 ·Status: RECRUITING ·Phase: PHASE3
-
Tirofiban After Successful MT Recanalization in AIS
NCT06265051 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Antiplatelet Therapy for AIS Patients With Thrombocytopenia
NCT06053021 ·Status: RECRUITING ·Phase: NA
-
The Bleeding With Antithrombotic Therapy Study 2
NCT02889653 ·Status: COMPLETED
-
Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
NCT06548971 ·Status: RECRUITING ·Phase: PHASE3
-
Biomarkers of Acute Stroke in Clinic
NCT03897478 ·Status: UNKNOWN
-
Alteplase in Elderly Acute Ischemic Stroke (AIS) Patients During Hospitalization
NCT05395351 ·Status: COMPLETED
-
Tenecteplase (TNK) in the Treatment of Intracerebral Hemorrhage (ICH)
NCT06696131 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
NCT06320431 ·Status: RECRUITING ·Phase: PHASE3
-
Clinical Trial Study About Human Adipose-Derived Stem Cells in the Stroke
NCT02813512 ·Status: COMPLETED ·Phase: PHASE1
-
Tenecteplase Thrombolytic Therapy for Acute Ischemic Stroke in China
NCT06078995 ·Status: RECRUITING
-
Preliminary Study of Pharmacokinetics of Ginkgolides Meglumine Injection.
NCT02046031 ·Status: COMPLETED ·Phase: PHASE4
-
SPT-07A Injection in Patients With Acute Ischemic Stroke (AIS): A Phase III Clinical Trial
NCT05159947 ·Status: UNKNOWN ·Phase: PHASE3
-
Thrombolysis Outcome in Ischemic Stroke
NCT04309357 ·Status: COMPLETED
-
Analysing the Effects of Xingnaojing for Mild-to-severe Acute Ischemic Stroke
NCT04813445 ·Status: UNKNOWN ·Phase: NA
-
Glyburide Advantage in Malignant Edema and Stroke Pilot
NCT01268683 ·Status: COMPLETED ·Phase: PHASE1/PHASE2